Denis Maillet

2.9k total citations
71 papers, 1.4k citations indexed

About

Denis Maillet is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Denis Maillet has authored 71 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 37 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Denis Maillet's work include Cancer Immunotherapy and Biomarkers (22 papers), Renal cell carcinoma treatment (17 papers) and Prostate Cancer Treatment and Research (17 papers). Denis Maillet is often cited by papers focused on Cancer Immunotherapy and Biomarkers (22 papers), Renal cell carcinoma treatment (17 papers) and Prostate Cancer Treatment and Research (17 papers). Denis Maillet collaborates with scholars based in France, United States and Australia. Denis Maillet's co-authors include Julien Péron, Benoît You, Hui Gan, Stéphane Dalle, Jean‐Jacques Stelmes, Eric X. Chen, Pauline Corbaux, Amélie Boespflug, M. Duruisseaux and Gregory R. Pond and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Denis Maillet

70 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Denis Maillet France 21 649 599 237 226 150 71 1.4k
Larysa Rydzewska United Kingdom 16 317 0.5× 1.0k 1.7× 157 0.7× 138 0.6× 181 1.2× 33 1.5k
Begoña de las Heras Spain 11 608 0.9× 321 0.5× 229 1.0× 318 1.4× 149 1.0× 27 1.8k
J. Cuzick United Kingdom 15 1.2k 1.9× 314 0.5× 296 1.2× 192 0.8× 812 5.4× 40 2.1k
Christina B. Ventura United States 14 754 1.2× 419 0.7× 204 0.9× 181 0.8× 344 2.3× 16 1.2k
Michael Ong Canada 17 1.1k 1.7× 451 0.8× 562 2.4× 362 1.6× 159 1.1× 89 1.8k
Allen S. Melemed United States 20 844 1.3× 352 0.6× 88 0.4× 237 1.0× 396 2.6× 43 1.4k
Ulrich‐Peter Rohr Germany 15 513 0.8× 296 0.5× 86 0.4× 285 1.3× 98 0.7× 25 1.2k
Laura Ciccolallo Italy 15 1.0k 1.6× 419 0.7× 339 1.4× 303 1.3× 140 0.9× 18 1.7k
Brent Evans United States 17 964 1.5× 322 0.5× 343 1.4× 368 1.6× 610 4.1× 45 2.1k

Countries citing papers authored by Denis Maillet

Since Specialization
Citations

This map shows the geographic impact of Denis Maillet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis Maillet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis Maillet more than expected).

Fields of papers citing papers by Denis Maillet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denis Maillet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis Maillet. The network helps show where Denis Maillet may publish in the future.

Co-authorship network of co-authors of Denis Maillet

This figure shows the co-authorship network connecting the top 25 collaborators of Denis Maillet. A scholar is included among the top collaborators of Denis Maillet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denis Maillet. Denis Maillet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fassi-Fehri, H., et al.. (2025). Predicting recurrence and progression in NMIBC: A multi-event and temporal analysis approach. PubMed. 35(9). 102921–102921.
2.
Oudard, Stéphane, Olivier Colomban, Karim Fizazi, et al.. (2024). Prognostic Value of the Modeled Prostate-Specific Antigen KELIM Confirmation in Metastatic Castration-Resistant Prostate Cancer Treated With Taxanes in FIRSTANA. JCO Clinical Cancer Informatics. 8(8). e2300208–e2300208. 2 indexed citations
3.
Saad, Fred, Andrew J. Armstrong, Karina Vianna, et al.. (2024). Tolerability of Olaparib Combined with Abiraterone in Patients with Metastatic Castration-resistant Prostate Cancer: Further Results from the Phase 3 PROpel Trial. European Urology Oncology. 7(6). 1394–1402. 7 indexed citations
4.
Freymond, N., Gilles Boschetti, Fanny Lebossé, et al.. (2024). Evolving Practices in Immune-Related Adverse Event Management: Insights From the IMMUCARE Multidisciplinary Board. JCO Oncology Practice. 21(3). 342–350. 3 indexed citations
5.
Péron, Julien, Denis Maillet, Stéphane Dalle, et al.. (2024). Synergistic effect between denosumab and immune checkpoint inhibitors (ICI)? A retrospective study of 268 patients with ICI and bone metastases. Journal of bone oncology. 48. 100634–100634. 1 indexed citations
6.
Maillet, Denis, Thomas Bochaton, François Delahaye, et al.. (2024). Recommandations de dépistage en France : une revue systématique. Santé Publique. vol. 36(5). 15–35. 1 indexed citations
7.
Elaidi, Réza, Olivier Colomban, Denis Maillet, et al.. (2022). Modeled Early Longitudinal PSA Kinetics Prognostic Value in Rising PSA Prostate Cancer Patients after Local Therapy Treated with ADT +/− Docetaxel. Cancers. 14(3). 815–815. 4 indexed citations
8.
Colomba, Émeline, Luca Campedel, Clément Dumont, et al.. (2022). Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study. Cancers. 14(7). 1678–1678. 7 indexed citations
9.
Rousset, Xavier, Denis Maillet, Sara Calattini, et al.. (2022). Embryonated Chicken Tumor Xenografts Derived from Circulating Tumor Cells as a Relevant Model to Study Metastatic Dissemination: A Proof of Concept. Cancers. 14(17). 4085–4085. 9 indexed citations
10.
Auclin, Édouard, Brigitte Laguerre, Mathilde Cancel, et al.. (2021). Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer. Cancer Medicine. 10(18). 6304–6309. 7 indexed citations
11.
Piperno, Muriel, Marie Kostine, Denis Maillet, et al.. (2021). Effets secondaires rhumatologiques immuno-induits par les inhibiteurs de points de contrôle de la réponse immunitaire. Bulletin du Cancer. 108(6). 643–653. 2 indexed citations
12.
Szabados, Bernadett, Alejo Rodríguez‐Vida, Ignacio Durán, et al.. (2020). 199O A phase II study investigating neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive bladder cancer: Final analysis. Annals of Oncology. 31. S1319–S1319. 3 indexed citations
13.
Péron, Julien, et al.. (2020). 1038P Impact of metastatic location on immune-checkpoint inhibitors efficacy in patients with different solid tumours. Annals of Oncology. 31. S714–S714. 1 indexed citations
14.
Barthélémy, Philippe, Clément Dumont, Brigitte Laguerre, et al.. (2020). 735P Metastatic renal medullary and collecting duct carcinoma in the era of antiangiogenic and immune checkpoint inhibitors: A multicentric retrospective study. Annals of Oncology. 31. S574–S574. 3 indexed citations
15.
16.
Maillet, Denis, Pauline Corbaux, Jean‐Jacques Stelmes, et al.. (2020). Association between immune-related adverse events and long-term survival outcomes in patients treated with immune checkpoint inhibitors. European Journal of Cancer. 132. 61–70. 56 indexed citations
17.
Berzero, Giulia, Bastien Herlin, Damien Ricard, et al.. (2019). Guillain-Barré Syndrome During Platinum-Based Chemotherapy: A Case Series and Review of the Literature. The Oncologist. 25(1). e194–e197. 10 indexed citations
18.
Loriot, Yohann, S. Supiot, Jean‐Baptiste Beauval, et al.. (2018). Management of non-metastatic castrate-resistant prostate cancer: A systematic review. Cancer Treatment Reviews. 70. 223–231. 17 indexed citations
19.
Pignot, G., Denis Maillet, Philippe Barthélémy, et al.. (2018). Systemic treatments for high-risk localized prostate cancer. Nature Reviews Urology. 15(8). 498–510. 36 indexed citations
20.
Péron, Julien, Denis Maillet, Hui Gan, Eric X. Chen, & Benoît You. (2013). Adherence to CONSORT Adverse Event Reporting Guidelines in Randomized Clinical Trials Evaluating Systemic Cancer Therapy: A Systematic Review. Journal of Clinical Oncology. 31(31). 3957–3963. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Larysa Rydzewska Breakdown of academic impact, for papers by Begoña de las Heras Breakdown of academic impact, for papers by J. Cuzick Breakdown of academic impact, for papers by Christina B. Ventura Breakdown of academic impact, for papers by Michael Ong Breakdown of academic impact, for papers by Allen S. Melemed Breakdown of academic impact, for papers by Ulrich‐Peter Rohr Breakdown of academic impact, for papers by Laura Ciccolallo Breakdown of academic impact, for papers by Brent Evans
Rankless by CCL
2026